Showing results (1-10 of 251) with videos related to
Sort By:
Pageof 26
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Hyperhomocyst(e)inemia: a risk factor for cerebrovascular diseaseLucilla Parnetti, Valeria Caso, Serena Amici, et al.Journal of Neurology|May 9, 2003
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patientsValeria Caso, Lucilla Parnetti, Paolo Panarelli, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Phospholipid autoantibodies: time for a new immuno-assay?Valeria Caso, Paolo Panarelli, Elisabetta Albi, et al.Cerebrovascular Diseases (Basel, Switzerland)|January 7, 2004
Recanalization of cervical artery dissection: influencing factors and role in neurological outcomeValeria Caso, Maurizio Paciaroni, Francesco Corea, et al.European Neurology|April 10, 2004
Dysphagia following StrokeMaurizio Paciaroni, Giovanni Mazzotta, Francesco Corea, et al.Expert Review of Neurotherapeutics|April 28, 2005
Nerve growth factor and chronic daily headache: a potential implication for therapyPaola Sarchielli, Virgilio GallaiCerebrovascular Diseases (Basel, Switzerland)|March 21, 2003
Is ultrasound examination sufficient in the evaluation of patients with internal carotid artery severe stenosis or occlusion?Maurizio Paciaroni, Valeria Caso, Gabriela Cardaioli, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Carotid endarterectomy in symptomatic patients with severe internal carotid artery stenosisMaurizio Paciaroni, Virgilio GallaiClinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Genetics of ischemic strokeMichele Venti, Lucilla Parnetti, Virgilio GallaiClinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Glicoprotein (GP) IIb/IIIa inhibitors for acute stroke treatmentJulien Bogousslavsky, Maurizio Paciaroni, Virgilio GallaiPageof 26